| Application no. and date | 01991753.3 (espacenet) (Federated) (European Patent Register), 20011122 | | Patent/reg. no. and date | DK/EP 1335987, 20051228 | | Publication date | 20030820 | | Priority no. and date | DK 200001764, 20001123 | | EP pub. no. and date |
EP 1335987 20030820 | | Effective date | | | Applicant/owner | BAVARIAN NORDIC A/S, Philip Heymans Alle 3, 2900 Hellerup, DK | | Applicant ref. no. | BAV BN35PCT-EP_amends | | Inventor | HOWLEY, Paul, Kopernikusweg 9
82152 Martinsried, DE,
MEISINGER, Christine, Kirchenstrasse 9
82194 Gröbenzell, DE,
CHAPLIN, Paul, Wohlerstrasse 22
81247 München, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/285 (2006.01) , A61K 48/00 (2006.01) , C12N 15/39 (2006.01) , C12N 15/863 (2006.01) , C12N 7/04 (2006.01) | | Title | MODIFICERET VARIANT AF VACCINIA VIRUS ANKARA | | Int. application no. | EP2001013628 | | Int. publication no. | WO2002042480 | | Related patent (certificate) | CA 2013 00057 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
